If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Pre-Close Trading Update

28 Mar 2014 07:02

RNS Number : 4235D
ITE Group PLC
28 March 2014
 



 

28 March 2014

ITE Group plc

("ITE" or the "Group")

Interim results pre-close statement

ITE Group plc is today publishing a pre-close statement ahead of its interim results for the six months ended 31 March 2014 which will be announced on Monday 19 May 2014.

Trading

Revenue for the six month period to 31 March 2014 is estimated to be circa £72m, (six months to 31 March 2013: £69m). The revenue for this period reflects a stronger biennial pattern and good trading, off-set by negative currency movements. Like for like revenues over the first six months are 10% ahead of the prior year on a constant currency basis and 2% behind on an actual basis. These factors together with a first-time profit contribution from the recently acquired Chinacoat event which took place in November last year will help the Group produce record profits for the period.

Ukraine

The Group's exhibitions in Ukraine all take place in Kiev and to date the office has been able to run its exhibition calendar without putting the safety of staff or customers at risk. We continue to monitor the situation closely and are currently expecting to run the remaining events scheduled for this financial year. Sales for the Ukrainian business have been affected by the recent crisis, and we estimate that there will be a negative effect on the Group's profits of circa £2m this financial year, the majority of which will be reported in the second half of the year. During the full year ended 30 September 2013, Ukraine contributed 6% of Group revenue and 7% of Group profits.

Currency movements

As previously noted, the Group is exposed to movements in foreign currency exchange rates against Sterling for most of its overseas operations. The larger exposures are to the Euro, Ruble, Turkish Lira and the Kazakh Tenge which with the exception of the Euro, have all weakened significantly against Sterling during the period. If current exchange rates prevail for the remainder of the financial year, the Group estimates that the effect of translation differences on full year like for like revenues will be in the region of 13%, though the effect on profits is expected to be partly mitigated by natural currency hedging and partly by underlying growth in our revenue base.

Financial position

The Group's balance sheet remains strong with net debt of £4m at 26 March 2014, and facilities of £30m in place to 30 June 2015.

Outlook

As at 26 March 2014, the Group has contracted revenues of £146m for the full year which on a like-for-like basis is 4% less than this time last year. On a constant currency basis like for like revenues would be 8% ahead of revenues for this time last year. The Group continues to monitor the political uncertainty surrounding Ukraine and Russia, and the potential effect on sales in those countries. An update will be provided in the Interim results announcement.

Ends

 

Enquiries:

 

Russell Taylor, Chief Executive, ITE Group plc

Tel: 020 7596 5000

Neil Jones, Group Finance Director, ITE Group plc

Tel: 020 7596 5000

Charles Palmer/Emma Appleton, FTI Consulting

Tel: 020 3727 1000

James Serjeant, Numis Securities Ltd

Tel: 020 7260 1309

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGZFVRMGDZG
Date   Source Headline
9th Mar 20222:09 pmRNSHolding(s) in Company
7th Mar 20224:27 pmRNSHolding(s) in Company
3rd Mar 20229:55 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSDirector/PDMR Shareholding
2nd Mar 202212:23 pmRNSDirector/PDMR Shareholding
1st Mar 20221:41 pmRNSHolding(s) in Company
28th Feb 20224:21 pmRNSHolding(s) in Company
28th Feb 20221:24 pmRNSResponse to the Russia/Ukraine conflict
28th Feb 202211:06 amRNSHolding(s) in Company
11th Feb 202212:50 pmRNSHolding(s) in Company
3rd Feb 20229:50 amRNSAnnouncement of Results of Annual General Meeting
3rd Feb 20227:00 amRNSBoard Changes
3rd Feb 20227:00 amRNSTrading Update
26th Jan 20222:50 pmRNSHolding(s) in Company
11th Jan 20229:33 amRNSHolding(s) in Company
5th Jan 202211:09 amRNSPublication of Annual Report and Notice of AGM
20th Dec 20213:17 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFY21 Preliminary Results
1st Dec 20217:00 amRNSVoting Rights and Capital
24th Nov 20215:17 pmRNSHolding(s) in Company
23rd Nov 20214:16 pmRNSHolding(s) in Company
23rd Nov 20211:59 pmRNSHolding(s) in Company
18th Nov 20211:54 pmRNSDirector/PDMR Shareholding
18th Nov 20219:41 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSProposed placing and direct subscription
11th Nov 20215:48 pmRNSCorrection - Director/PDMR Shareholding
26th Oct 20212:54 pmRNSDirector/PDMR Shareholding
25th Oct 202111:26 amRNSAnnouncement of Results of General Meeting
13th Oct 20211:16 pmRNSDirector Declaration
8th Oct 20219:28 amRNSNotice of General Meeting
7th Oct 20217:00 amRNSPre-close trading update
1st Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 20213:26 pmRNSHolding(s) in Company
20th Jul 20215:13 pmRNSHolding(s) in Company
13th Jul 20214:34 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSTrading Update
24th Jun 202110:38 amRNSHolding(s) in Company
23rd Jun 20219:13 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSResponse to recent press speculation
28th May 202111:48 amRNSHolding(s) in Company
26th May 202111:09 amRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
11th May 20212:16 pmRNSHolding(s) in Company
26th Apr 202112:44 pmRNSHolding(s) in Company
23rd Apr 20214:08 pmRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading Update
1st Apr 202110:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 202111:50 amRNSHolding(s) in Company
22nd Feb 20212:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.